Cargando…
Formulation and optimisation of raft-forming chewable tablets containing H(2) antagonist
PURPOSE: The purpose of this research work was to formulate raft-forming chewable tablets of H(2) antagonist (Famotidine) using a raft-forming agent along with an antacid- and gas-generating agent. MATERIALS AND METHODS: Tablets were prepared by wet granulation and evaluated for raft strength, acid...
Autores principales: | Prajapati, Shailesh T, Mehta, Anant P, Modhia, Ishan P, Patel, Chhagan N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3618633/ https://www.ncbi.nlm.nih.gov/pubmed/23580933 http://dx.doi.org/10.4103/2230-973X.106988 |
Ejemplares similares
-
Formulation and evaluation of sublingual tablets containing Sumatriptan succinate
por: Prajapati, Shailesh T, et al.
Publicado: (2012) -
Development of raft-forming liquid and chewable tablet formulations incorporating quercetin solid dispersions for treatment of gastric ulcers
por: Bunlung, Suputra, et al.
Publicado: (2021) -
Formulation and Evaluation of Controlled-Release Tablet of Zolpidem Tartrate by Melt Granulation Technique
por: Prajapati, Shailesh T., et al.
Publicado: (2011) -
Development of Bioadhesive Chitosan Superporous Hydrogel Composite Particles Based Intestinal Drug Delivery System
por: Chavda, Hitesh, et al.
Publicado: (2013) -
Formulation development of chewable albendazole tablets with improved dissolution rate
por: Kimaro, Emmanuel, et al.
Publicado: (2019)